VADDI KRISHNA (President, CEO) purchased 517.2% of their position (106.89K shares) of PRELUDE THERAPEUTICS INC on the open market
Open‑market purchase worth $99.3K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 12/20/2024ACC: 0001562180-24-008531
DirectorOfficer· President, CEO
Since Sep 2020
+106.89K
Net shares
Net buyer
$99.3K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
106.89K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+100K
Price / share
$0.93
Trade value
$93.21K
% of position
9.4%
12/18/2024
1.07M→1.17M
Common Stock
Indirect
Shares
+6.89K
Price / share
$0.89
Trade value
$6.12K
% of position
5.7%
12/19/2024
120.67K→127.55K
Total
Net shares
+106.89K
Net value
$99.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/18/2024 | P · Purchase | +100K | $0.93 | $93.21K | 9.4% | 1.07M | 1.17M |
| Common Stock Indirect | 12/19/2024 | P · Purchase | +6.89K | $0.89 | $6.12K | 5.7% | 120.67K | 127.55K |
| Total | +106.89K | $99.33K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned551.78K
Common Stock
IndirectShares owned423.67K
Common Stock
IndirectShares owned551.77K
Total
1.53M indirect1.53M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 551.78K | Indirect |
| Common Stock | 423.67K | Indirect |
| Common Stock | 551.77K | Indirect |
| Total | 1.53M | 1.53M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported